Dmitry N Kaluzhny Selected Research

LCTA-2034

11/2017

Development and pharmaceutical evaluation of the anticancer Anthrafuran/Cavitron complex, a prototypic parenteral drug formulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dmitry N Kaluzhny Research Topics

Disease

11	Neoplasms (Cancer) 10/2022 - 10/2009
3	Carcinoma (Carcinomatosis) 01/2014 - 10/2009
1	Leukemia 10/2022
1	Prostatic Neoplasms (Prostate Cancer) 03/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Hypoxia (Hypoxemia) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Anthrax 11/2017
1	Melanoma (Melanoma, Malignant) 11/2017
1	Phototoxic Dermatitis (Phototoxicity) 09/2016

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 10/2021 - 10/2014
4	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 10/2009
2	AnthraquinonesIBA 10/2022 - 03/2019
2	furanIBA 03/2019 - 11/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2014 - 01/2014
2	carbazoleIBA 01/2011 - 10/2009
1	quinolineIBA 10/2022
1	indoleIBA 10/2022
1	compound 17IBA 10/2022
1	HalogensIBA 03/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Histidine (L-Histidine)FDA Link 01/2020
1	IonsIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	ZincIBA 01/2020
1	Amyloid beta-PeptidesIBA 01/2020
1	EmulsionsIBA 01/2018
1	FluorocarbonsIBA 01/2018
1	Photosensitizing Agents (Photosensitizers)IBA 01/2018
1	PorphyrinsIBA 01/2018
1	hydrogen sulfite (bisulfite)IBA 01/2018
1	heliomycinIBA 01/2018
1	LCTA-2034IBA 11/2017
1	CyclodextrinsIBA 11/2017
1	Human Serum Albumin FDA LinkGeneric 09/2016
1	Proteins (Proteins, Gene)FDA Link 09/2016
1	Topoisomerase I InhibitorsIBA 01/2014
1	Protein Kinases (Protein Kinase)IBA 01/2014
1	Antineoplastic Agents (Antineoplastics)IBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2011
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 10/2009

Therapy/Procedure

1	Therapeutics 03/2022